Proflavanol 90
Natural health product licensed in Canada
- Licence holder
- USANA Health Sciences
- NPN or DIN-HM
- 80002053
- Status
- Inactive licence
- Licence date
- 29 August 2006
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine C | 300 mg | Not calculated |
Non-medicinal ingredients
Cellulose, microcristalline, lécithine de soja, Dextrose, Dioxyde de silicium, Croscarmellose de sodium, Amidon prégélatinisé, Dextrine, Palmitate d'ascorbyle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Comprimé | Not specified |
Uses authorised in Canada
Provides antioxidant support to neutralize free radicals and promote long-term health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
For adult use only. Keep out of reach of children. Do not use if pregnant or breastfeeding. Consult a health care practitioner before use, if you are taking a blood-thinning medication.
- Contre-indications
None known
- Effets indésirables connus
None known
Source
Official Health Canada record, licence 80002053
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.